Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears).

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Abstract Text:

L Sharp,S C Cotton,L Alexander,E Williams,N M Gray,J M Reid,L Sharp,S C Cotton,L Alexander,E Williams,N M Gray,J M Reid, ,L Sharp,S C Cotton,L Alexander,E Williams,N M Gray,J M Reid, ,

BACKGROUND: Better understanding of motivators for, and barriers to, participation in randomized controlled trials (RCTs) in different study populations and settings has the potential to improve participation of historically under-represented groups (eg, women) in future trials. PURPOSE: To investigate reasons why women agreed, or declined, to participate in a RCT. METHODS: In two postal questionnaire-based studies, we investigated women's reasons for participation or non-participation in TOMBOLA, a RCT comparing management policies for low-grade cervical abnormalities. Four-hundred and ninety-two TOMBOLA participants (response rate 56%) completed questionnaires on reasons for participation. One-hundred and thiry-seven women (38%) who declined TOMBOLA participation completed questionnaires on reasons for this. RESULTS: Eighty percent of women reported that one of their reasons for attending their TOMBOLA recruitment appointment was worries about their smear result. Ninety-four percent participated in the RCT because it was a worthwhile contribution to the cervical screening programme and other women; for 70% this was the most important reason. These proportions did not vary by socio-demographic factors. Thirty-two percent thought participation would result in better care. The most common reason for non-participation was preference for follow-up from the woman's GP. Logistical issues (eg, inconvenient appointments, travel time, arranging time off work or child-care) were commonly cited. Fourteen percent were too frightened to participate; this was unrelated to the grade of the recruitment smear. LIMITATIONS: Response rates were not high, but there was little evidence of response bias. Structured questionnaires were used. CONCLUSIONS: Future research should address how best to deliver information to ensure different social groups appreciate potential benefits of RCT participation and provide reassurance regarding fears about participation. Simple strategies (eg, appealing to the altruism of potential participants or offering flexible recruitment clinic locations and times) might enhance RCT recruitment rates. This in turn would ensure best use of research resources thus bringing the greatest benefits to participants and the population.

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Publishing Authors By Initials

L Sharp,SC Cotton,L Alexander,E Williams,NM Gray,JM Reid,L Sharp,SC Cotton,L Alexander,E Williams,NM Gray,JM Reid, ,L Sharp,SC Cotton,L Alexander,E Williams,NM Gray,JM Reid, ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical trials (London, England)

VOLUME: 3

Page Numbers: 431-42

Journal Abbreviation:

ISSN: 1740-7745

DAY: 24

MONTH: 10

YEAR: 2006

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101197451

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears).

AFFILIATION: National Cancer Registry Ireland, Cork, Ireland.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Trials

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA Trial Of Management of Borderline and Other Low-grade Abnormal smears Related Publications

• A review on the genetics of otosclerosis.
• Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein.
• Are exotic natural enemies an effective way of controlling invasive plants?
• Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment.
• Bisphosphonates.
• Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
• Co-regulation of the nitrogen-assimilatory gene cluster in Clostridium saccharobutylicum.
• Delayed Onset Muscle Soreness Following Inspiratory Threshold Loading In Healthy Men and Women: 681: May 31 9:30 AM - 9:45 AM.
• Demonstration of artificial visual percepts generated through thalamic microstimulation.
• Design of a 2 T multipole wiggler insertion device for the SRS.
• Digital three-dimensional modelling of the male pelvis and bicycle seats: impact of rider position and seat design on potential penile hypoxia and erectile dysfunction.
• Efficacy of murine monoclonal antibodies in RBC phenotyping of DAT-positive samples.
• Emerging methods in proteomics: top-down protein characterization by multistage tandem mass spectrometry.
• Femtosecond pump-probe studies of nitrosyl chloride photochemistry in solution.
• Genetic variability of Trypanosoma evansi isolates detected by inter-simple sequence repeat anchored-PCR and microsatellite.
• Globular clusters, hipparcos, and the age of the galaxy.
• Human hepatoblast phenotype maintained by hyaluronan hydrogels.
• Importance and the role of parents in specific learning disabilities.
• Inflammatory disease-induced muscle wasting: 105: 3:30 PM-4:00 PM.
• NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
• Optical properties of micrometer size water droplets studied by cavity ringdown spectroscopy.
• Organisms associated with bacterial vaginosis in Nigerian women as determined by PCR-DGGE and 16S rRNA gene sequence.
• Oxidative stress, chronic disease, and muscle wasting.
• Patient-centered outcomes for frequent headaches.
• Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance).
• Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears).
• Sex after seventy: a pilot study of sexual function in older persons.
• The phenotypes of pluripotent human hepatic progenitors.
• The potential role of phosphodiesterase inhibitors in the management of asthma.
• Three new high-prevalence antigens in the Cromer blood group system.